Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Ellen Caroline Feitoza PiresDepartment of Biotechnology, Molecular Biology Laboratory, Federal University of Tocantins, Gurupi 77410-570, Brazil.ORCID 0000-0001-8376-9904
Francini Pereira da SilvaInstitute of Health Sciences, Molecular Microbiology Laboratory, Feevale University, Novo Hamburgo 93525-075, Brazil.
Karoline SchallenbergerInstitute of Health Sciences, Molecular Microbiology Laboratory, Feevale University, Novo Hamburgo 93525-075, Brazil.ORCID 0000-0002-4418-0766
Bruna Saraiva HermannInstitute of Health Sciences, Molecular Microbiology Laboratory, Feevale University, Novo Hamburgo 93525-075, Brazil.ORCID 0000-0002-7747-7064
Larissa MallmannInstitute of Health Sciences, Molecular Microbiology Laboratory, Feevale University, Novo Hamburgo 93525-075, Brazil.ORCID 0000-0003-0456-3030
Wellington Souza MouraDepartment of Biotechnology Biodiversity and Graduate School of Biotechnology of Amazônia (Bionorte), Natural Products Laboratory, Federal University of Tocantins, Gurupi 77410-570, Brazil.ORCID 0000-0002-3966-8601
Sergio Donizeti AscêncioDepartment of Biotechnology Biodiversity and Graduate School of Biotechnology of Amazônia (Bionorte), Natural Products Laboratory, Federal University of Tocantins, Gurupi 77410-570, Brazil.
Robson Dos Santos BarbosaDepartment of Biotechnology Biodiversity and Graduate School of Biotechnology of Amazônia (Bionorte), Natural Products Laboratory, Federal University of Tocantins, Gurupi 77410-570, Brazil.
Ilsamar Mendes SoaresDepartment of Biotechnology Biodiversity and Graduate School of Biotechnology of Amazônia (Bionorte), Natural Products Laboratory, Federal University of Tocantins, Gurupi 77410-570, Brazil.ORCID 0000-0001-7083-4172
Juliane Deise FleckInstitute of Health Sciences, Molecular Microbiology Laboratory, Feevale University, Novo Hamburgo 93525-075, Brazil.
Eugênio Eduardo de OliveiraDepartamento de Entomologia, Universidade Federal de Viçosa, Viçosa 36570-900, Brazil.ORCID 0000-0003-1174-6564
Guy SmaggheDepartment of Plants and Crops, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0001-8334-3313
Bergmann Morais RibeiroDepartment of Cell Biology, Institute of Biology, University of Brasília, Brasília 70910-900, Brazil.ORCID 0000-0002-1061-196X
Raimundo Wagner de Souza AguiarDepartment of Biotechnology, Molecular Biology Laboratory, Federal University of Tocantins, Gurupi 77410-570, Brazil.
Funding
CAPES Foundation Finnance Code 001Conselho Nacional De Desenvolvimento Científico E Tecnológico 313455/2019-8; 427304/2018-0; 308576/2018-7; 408598/2023-9 309890/2022-5Federal University of Tocantins PROPESQ - EDITAL Nº 29/2020 PROPESQ, and PPGBIOTEC/UFT/GURUPI- Chamada pública para auxílio de tradução e/ou publicação de artigos científicos - EDITAL Nº 011/2020Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-03771-18Fundação de apoio à pesquisa do Distrito Federal 00193-00002148/2023-27Tocantins State Foundation for Research Aid FAPT-SESAU/TO-DECIT/SCTIE/MS_CNPQ/N° 01/2017
6 · The paper itself
Abstract
Chikungunya and Mayaro fevers are viral infectious diseases characterized by fever and arthralgia, for which there are currently no effective vaccines or treatments. The urgent need for novel antiviral agents against Chikungunya virus (CHIKV) and Mayaro virus (MAYV) has led to interest in plant-based compounds that can disrupt the viral replication cycle.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Antiviral Potential of · full record | OpenQuestion